Co-expression and prognosis analyses of GLUT1 –4 and RB1 in breast cancer

Current treatment methods for patients with triple-negative breast cancer (TNBC) are very limited, and the prognosis of TNBC is relatively poor. It has been reported that glucose transporter 1 (GLUT1) is overe...

Source: BMC Cancer - September 15, 2021 Category: Cancer & Oncology Authors: Xiaodan Zhang, Xiaocong Pang, Zhuo Zhang, Qianxin Liu, Hanxu Zhang, Qian Xiang and Yimin Cui Tags: Research Source Type: research